Transgenic shRNA pigs reduce susceptibility to foot and mouth disease virus infection

  1. Shengwei Hu
  2. Jun Qiao
  3. Qiang Fu
  4. Chuangfu Chen  Is a corresponding author
  5. Wei Ni
  6. Sai Wujiafu
  7. Shiwei Ma
  8. Hui Zhang
  9. Jingliang Sheng
  10. Pengyan Wang
  11. Dawei Wang
  12. Jiong Huang
  13. Lijuan Cao
  14. Hongsheng Ouyang
  1. Shihezi University, China
  2. Xinjiang Academy of Animal Science, China
  3. Jilin University, China

Abstract

Foot-and-mouth disease virus (FMDV) is an economically devastating viral disease leading to a substantial loss to the swine industry worldwide. A novel alternative strategy is to develop pigs that are genetically resistant to infection. Here, we produce transgenic (TG) pigs that constitutively expressed FMDV-specific siRNA derived from small hairpin RNA (shRNA). In vitro challenge of TG fibroblasts showed the shRNA suppressed viral growth. TG and non-transgenic (Non-TG) pigs were challenged by intramuscular injection with 100 LD50 of FMDV. High fever, severe clinical sign of FMD and typical histopathological changes were observed in all of the Non-TG pigs but in none of the high-siRNA pigs. Our results show that transgenic shRNA can provide a viable tool for producing animals with enhanced resistance to FMDV.

Article and author information

Author details

  1. Shengwei Hu

    College of Life Sciences, Shihezi University, Shihezi, China
    Competing interests
    The authors declare that no competing interests exist.
  2. Jun Qiao

    College of Life Sciences, Shihezi University, Shihezi, China
    Competing interests
    The authors declare that no competing interests exist.
  3. Qiang Fu

    College of Life Sciences, Shihezi University, Shihezi, China
    Competing interests
    The authors declare that no competing interests exist.
  4. Chuangfu Chen

    College of Life Sciences, Shihezi University, Shihezi, China
    For correspondence
    chencf1962@yahoo.com
    Competing interests
    The authors declare that no competing interests exist.
  5. Wei Ni

    College of Animal Sciences, Shihezi University, Shihezi, China
    Competing interests
    The authors declare that no competing interests exist.
  6. Sai Wujiafu

    College of Life Sciences, Shihezi University, Shihezi, China
    Competing interests
    The authors declare that no competing interests exist.
  7. Shiwei Ma

    College of Life Sciences, Shihezi University, Shihezi, China
    Competing interests
    The authors declare that no competing interests exist.
  8. Hui Zhang

    College of Life Sciences, Shihezi University, Shihezi, China
    Competing interests
    The authors declare that no competing interests exist.
  9. Jingliang Sheng

    College of Life Sciences, Shihezi University, Shihezi, China
    Competing interests
    The authors declare that no competing interests exist.
  10. Pengyan Wang

    College of Life Sciences, Shihezi University, Shihezi, China
    Competing interests
    The authors declare that no competing interests exist.
  11. Dawei Wang

    College of Life Sciences, Shihezi University, Shihezi, China
    Competing interests
    The authors declare that no competing interests exist.
  12. Jiong Huang

    Institute of Veterinary Medicine, Xinjiang Academy of Animal Science, Urumqi, China
    Competing interests
    The authors declare that no competing interests exist.
  13. Lijuan Cao

    College of Life Sciences, Shihezi University, Shihezi, China
    Competing interests
    The authors declare that no competing interests exist.
  14. Hongsheng Ouyang

    College of Animal Science and Veterinary Medicine, Jilin University, Changchun, China
    Competing interests
    The authors declare that no competing interests exist.

Ethics

Animal experimentation: All experiments involving animals were conducted under the protocol approved by the Animal Care and Use Committee of Shihezi University (SU-ACUC-12031).

Copyright

© 2015, Hu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,126
    views
  • 507
    downloads
  • 33
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Shengwei Hu
  2. Jun Qiao
  3. Qiang Fu
  4. Chuangfu Chen
  5. Wei Ni
  6. Sai Wujiafu
  7. Shiwei Ma
  8. Hui Zhang
  9. Jingliang Sheng
  10. Pengyan Wang
  11. Dawei Wang
  12. Jiong Huang
  13. Lijuan Cao
  14. Hongsheng Ouyang
(2015)
Transgenic shRNA pigs reduce susceptibility to foot and mouth disease virus infection
eLife 4:e06951.
https://doi.org/10.7554/eLife.06951

Share this article

https://doi.org/10.7554/eLife.06951

Further reading

    1. Microbiology and Infectious Disease
    Li Zhang, Fen Hu ... Hang Yang
    Research Article

    Phage-derived peptidoglycan hydrolases (i.e. lysins) are considered promising alternatives to conventional antibiotics due to their direct peptidoglycan degradation activity and low risk of resistance development. The discovery of these enzymes is often hampered by the limited availability of phage genomes. Herein, we report a new strategy to mine active peptidoglycan hydrolases from bacterial proteomes by lysin-derived antimicrobial peptide-primed screening. As a proof-of-concept, five peptidoglycan hydrolases from the Acinetobacter baumannii proteome (PHAb7-PHAb11) were identified using PlyF307 lysin-derived peptide as a template. Among them, PHAb10 and PHAb11 showed potent bactericidal activity against multiple pathogens even after treatment at 100°C for 1 hr, while the other three were thermosensitive. We solved the crystal structures of PHAb8, PHAb10, and PHAb11 and unveiled that hyper-thermostable PHAb10 underwent a unique folding-refolding thermodynamic scheme mediated by a dimer-monomer transition, while thermosensitive PHAb8 formed a monomer. Two mouse models of bacterial infection further demonstrated the safety and efficacy of PHAb10. In conclusion, our antimicrobial peptide-primed strategy provides new clues for the discovery of promising antimicrobial drugs.